Androgen-induced differentiation and tumorigenicity of human prostate epithelial cells

R Berger, PG Febbo, PK Majumder, JJ Zhao… - Cancer research, 2004 - AACR
R Berger, PG Febbo, PK Majumder, JJ Zhao, S Mukherjee, S Signoretti, KT Campbell…
Cancer research, 2004AACR
Androgen ablation is the primary treatment modality for patients with metastatic prostate
cancer; however, the role of androgen receptor signaling in prostate cancer development
remains enigmatic. Using a series of genetically defined immortalized and tumorigenic
human prostate epithelial cells, we found that introduction of the androgen receptor induced
differentiation of transformed prostate epithelial cells to a luminal phenotype reminiscent of
organ-confined prostate cancer when placed in the prostate microenvironment. Moreover …
Abstract
Androgen ablation is the primary treatment modality for patients with metastatic prostate cancer; however, the role of androgen receptor signaling in prostate cancer development remains enigmatic. Using a series of genetically defined immortalized and tumorigenic human prostate epithelial cells, we found that introduction of the androgen receptor induced differentiation of transformed prostate epithelial cells to a luminal phenotype reminiscent of organ-confined prostate cancer when placed in the prostate microenvironment. Moreover, androgen receptor expression converted previously androgen-independent, tumorigenic prostate epithelial cells into cells dependent on testosterone for tumor formation. These observations indicate that androgen receptor expression is oncogenic and addictive for the human prostate epithelium.
AACR